Designing pure + safe ingredients. Driven by consumers and backed by science and data, not hype. Nalu is developing high-quality, consistent, cost effective, ingredients for wellness and therapeutics.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $12M
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Brown Ange... | brownangel... |
| - | XFactor Ve... | xfactor.ve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.02.2023 | Series A | $12M | Portfolia |
Mentions in press and media 7
| Date | Title | Description |
| 28.02.2023 | Nalu Bio Receives $12M Series A Round | SAN FRANCISCO, CA, Nalu Bio, a producer of chemistry-based, ultra-pure cannabinoids, today announced that it has raised a $12 million Series A funding round. >> Click here for more funding data on Nalu Bio >> To export Nalu ... |
| 28.02.2023 | Nalu Bio Raises $12M in Series A Funding | Nalu Bio, a San Francisco, CA-based producer of chemistry-based cannabinoids, raised $12M in Series A funding. The round was led by Intrinsic Capital Partners, with participation from Flybridge Capital Partners, Portfolia Active Aging &... |
| 19.07.2022 | Bonaventure Equity Announces Follow-On Investment in Nalu Bio | www.bve.vc Nalu Bio, Inc., is creating a new category of cannabinoids, fundamentally disrupting their agricultural production for the wellness and pharmaceutical markets. Founders who make a plan and execute tirelessly to achieve milestones... |
| 03.08.2021 | Meet Ross O'Brien, founder of Bonaventure Equity | Bonaventure is a boutique venture capital firm focused on companies in the cannabis space Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there ar... |
| 15.04.2021 | Why Synthetic Cannabinoids Can Be a Good Thing | April 15, 2021 4 min read Opinions expressed by Entrepreneur contributors are their own. The use of synthetic cannabinoids is a controversial issue in the cannabis industry. It could be an opportunity to advance the research and development... |
| 26.02.2021 | Is Synthetic CBD the Next Big Thing? | February 26, 2021 1 min read Caitlyn Krebs is the Co-Founder & CEO at Nalu Bio, a biopharmaceutical firm focused on designing synthetic CBD. Established in 2019, Nalu Bio's proprietary platform is unique in that its CBD is not hemp-base... |
| - | Nalu Bio | “Nalu Bio is the leading innovator in the production of ultra pure CBD using next generation cannabinoid ingredients.” |